Whalesbook
Q4 Results Ne Diya Dhamaka!
Prabhudas Lilladher ke hisaab se, Global Health ne fiscal year ka end kaafi strong kiya hai. Unka EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) Q4FY26 mein estimate se 6% zyada aaya hai aur pichle saal ke comparison mein 13% grow bhi hua hai. Iska bada credit Lucknow aur Patna wale hospitals ko jaata hai. Aur Noida unit mein bhi loss kam hua hai, jo ki achhi baat hai.
Expansion Plans Se Long-Term Growth Ka Vaada
Brokerage firm ko lagta hai ki Global Health FY26 se FY28 tak har saal EBITDA mein 24% ki zabardast growth dikhayegi. Yeh confidence isliye hai kyunki Lucknow wale unit ki problems solve ho gayi hain aur Noida facility bhi jaldi hi contribute karna start kar degi. Current mein company ke paas around 3,663 beds hain, aur agle 3 se 4 saal mein woh 3,190 aur beds add karne ka plan kar rahe hain. So, capacity bahut badhne wali hai.
Analyst Ne Kaha 'BUY', Target ₹1450!
In sab achhi cheezon ko dekh kar, Prabhudas Lilladher ne FY27 aur FY28 ke liye EBITDA estimates ko 6% badha diya hai. Unka 'BUY' recommendation ab bhi maintain hai aur target price ko ₹1450 set kiya gaya hai. Yeh valuation unhone FY28 ke earnings par 27x Enterprise Value to EBITDA multiple ke basis par calculate kiya hai.